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CHAPTER I 
ANALYSIS OF AN ALS MOUSE MODEL 
Abstract 
 Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease in which 
patients suffer from muscle weakness, paralysis, and eventually leading to death. There are 
two forms of this disease, familial and sporadic, both of which share only one approved 
treatment, Riluzole. Mutations in SOD1 account for about 2% of all cases of ALS. The 
exact mechanisms by which these mutations induce neurodegeneration remain unknown, 
although a variety of cell types contribute. In an effort to discover novel drug targets for 
ALS intervention, the transcriptomes of MCP1+ cells in affected SOD1 ALS mice and 
healthy control mice were examined. The specific populations studied originated in the 
motor cortex and the lumbar region of the spinal cord, which is where the diseased neurons 
are located, and were isolated using Fluorescence Activated Cell Sorting (FACS) by the 
presence of fluorescence driven by the MCP1 promoter. This study found numerous genes 
to be differentially expressed between mutant SOD1 and WT populations in both the motor 
cortex and the spinal cord. As there only one approved treatment, finding specific changes 
that could lead to new treatments is a priority, but further studies are required to achieve 
this goal.  
 
Introduction 
Amyotrophic Lateral Sclerosis 
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurological disorder marked by a 
degeneration of motor neurons in the spinal cord, motor cortex, and brainstem (Leblond et 
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al., 2014). This degeneration causes atrophy, tremors, and weakness in muscles, leading to 
paralysis and difficulty breathing and swallowing. Death usually results from respiratory 
failure (Chiò et al., 2013). Finding a cure, or even drug targets is problematic as there are 
two different subtypes, familial ALS (fALS) and sporadic ALS (sALS).  Sporadic cases 
are much more common with only about 10% of all cases being fALS.  To make it even 
more difficult, there are numerous different genes that have been implicated in occurrences 
of both sALS and fALS (Leblond et al., 2014; Renton et al., 2014).  
fALS and sALS are clinically indistinguishable from one another. The main 
difference between them is age of onset, which tends to be around a decade earlier for fALS 
patients (Leblond, et al., 2014). The range of ALS onset is between 45 and 60 years of age, 
and is usually fatal within 5 years (Boillée et al., 2006). Weakness and muscle atrophy are 
the first noticeable signs of motor neuron degeneration, but patients are only diagnosed 
with ALS if both the upper and lower motor neurons of the motor cortex and spinal cord 
show signs of degeneration. Occasionally one is present before the other, which can 
postpone diagnosis (McCombe and Henderson, 2011). The site of disease onset varies 
(spinal or bulbar) and some patients also experience frontal lobe dementia. The etiology of 
these variations is still unclear. Survival time has been shown to be correlated to age of 
onset and site of onset. As the age of onset increases, survival worsens, and bulbar onset 
has a shorter survival time than spinal onset (Chió et al.,2009). Disease progression is 
measured by estimation of functional motor unit quantity and serum levels of 
neurofilaments that are associated with axonal degeneration (McCombe and Henderson, 
2011).  
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Treatment of ALS 
As there is no cure, therapeutic targets have focused on symptom control and 
improving patients’ quality of life. While numerous therapeutic agents have been studied, 
Riluzole remains the only approved treatment of ALS that extends survival (Vucic et al., 
2014; Chió et al., 2009).  The mechanism by which Riluzole helps ALS is still uncertain. 
The use of Riluzole seems to promote neuron survival, probably by its enhancement of the 
production of neural growth factors (Bellingham, 2011). This treatment has a small but 
significant effect on improving lifespan, along with limb function, even though it does not 
improve muscle strength. Current research is investigating the possibility of other 
therapies, including stem cell treatments, modulation of gene expression, and strategies to 
encourage axonal growth (Vucic et al., 2014). As ALS is a multifactorial disease that 
includes genetic factors and molecular pathway interactions, a combination of treatments 
will probably be the most promising route in the future. 
Due to a lack of effective treatment, more avenues of potential therapy need to be 
explored. One option could be trying to control inflammation. There is considerable 
evidence of inflammation in ALS patients, but these studies have all examined end-stage 
tissues, so the timing of inflammation is uncertain (McCombe and Henderson, 2011). Glial 
scarring is seen in ALS patients, as astrocytes and microglia (resident cells of the central 
nervous system that are the first line of immune defense) appear to react to 
neuroinflammation in the brain and spinal cord. This immune response is most likely due 
to a release of signals from the diseased neurons and surrounding cells (Papadimitriou et 
al., 2009). One such signal is monocyte chemoattractant protein-1 (MCP-1). MCP-1 is a 
chemokine that selectively recruits monocytes (white blood cells involved in immune 
4 
 
response) and macrophages (cells involved in phagocytosis) to sites of inflammation 
(Deshmane et al., 2009). It is expressed mostly in astrocytes, but also in neurons, microglia 
and macrophages. It attracts cells expressing its receptor CCR2, bringing dendritic cells, 
macrophages and monocytes to sites of inflammation (Henkel et al., 2003). In 2003, Henkel 
et al., took samples from multiple deceased individuals with ALS and found that ALS 
patients have increased numbers of activated macrophages and increased levels of MCP-1 
in their spinal tissue (Henkel et al., 2003). Patients with comparatively higher levels of 
MCP-1 had more rapidly progressing disease symptoms which led to earlier death 
(McCombe and Henderson, 2011; Henkel et al., 2003).  
 
Genetics of ALS 
The first gene to be linked to fALS was Cu/Zn superoxide dismutase 1 (SOD1). 
This gene converts toxic superoxide radicals to hydrogen peroxide, which is then converted 
to water. Excess reactive free radicals have been known to be toxic and cause neuronal 
injury. In 1993, Rosen et al., identified 11 missense mutations on exons 2 and 4 of SOD1 
in 13 separate families with fALS (Rosen et al., 1993). We now know that about 20% of 
fALS cases are due to mutations found in all five exons of the SOD1 gene (Leblond et al., 
2014). There are over 160 identified mutations in the SOD1 gene (Vucic et al., 2014). It 
then took fifteen years for the next fALS gene to be identified. In 2008, Sreedheran et al., 
discovered a mutation in TAR-DNA binding protein 43 (TARDBP) (Sreedharan et al., 
2008). Due to new methods and technological advances, the rate of gene discovery in ALS 
cases has dramatically increased (Renton et al., 2014). The genes most prevalent in fALS 
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cases include SOD1, FUS (fused in sarcoma), TARDBP, and C9orf72 (chromosome 9 open 
reading frame 72) (Leblond et al., 2014; Renton et al., 2014).  
The discovery that SOD1 was linked to fALS led to the generation of a transgenic 
SOD1 ALS mouse model. Rats and mice with mutant SOD1 continue to be the most 
commonly used animal models of ALS, and the most reliable recapitulation of human 
symptoms (McCombe and Henderson, 2011; Maragakis and Rothstein, 2006). These 
models show a progressive weakness of muscles typical of ALS along with inflammation 
associated with sequential activation of caspase 1 and caspase 3, which leads to apoptosis 
in affected regions (Henkel et al. 2003; Pasinelli et al., 2000). The exact manner of immune 
response, such as robustness of specific immune cell response, differs among different 
models and backgrounds, as it differs among human patients. SOD1 mice demonstrate non-
specific inflammation that appears to make the disease worse, however it appears that it is 
not a primary cause of the disease as SOD1 mice without B cells and those without 
microglia have the same disease as otherwise normal SOD1 mice (Henkel et al. 2003). 
 
SOD1 and Oxidative Stress 
 There are multiple proposed mechanisms of neurodegeneration in ALS. Due to the 
prevalence of SOD1 mutations, oxidative stress is a promising candidate. Diseased tissues 
of ALS patients show evidence of oxidative damage, and transgenic SOD1 mouse models 
also display increased oxidative damage (Barber et al., 2006; Cristiana et al., 2014). To 
combat this, multiple clinical trials have been completed to examine the potential of anti-
oxidant therapies. So far there has not been significant improvement in any human trial 
(Barber et al., 2006).  
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The mechanisms by which SOD1 mutations cause ALS remain unclear. The 
increase of oxidative damage would suggest that SOD1 mutations cause a loss of function, 
but that is not the case. These are toxic gain of function mutations, as knocking out SOD1 
function does not result in motor neuron disease (Barber et al., 2006). To attempt to 
elucidate whether the toxic function of SOD1 is restricted to only the neurons or the 
astrocytes, cell type specific transgenic SOD1 mice were examined. When mutant SOD1 
was restricted to either the neurons or the astrocytes only, it was not sufficient to induce 
motor neuron disease (Barber et al., 2006). This is evidence for a role of both neurons and 
non-neuronal cells in ALS onset and progression. 
 
Project Goals  
The purpose of this project was to characterize the innate and adaptive immune 
response in hSOD1G93A-MCP1-CCR2 triple transgenic ALS mouse and to identify 
differentially expressed genes in diseased and healthy tissues. This involves a transgenic 
mouse with human SOD1 mutated from glycine to alanine at position 93 (hSOD1G93A) 
(Gurney et al., 1994). These heterozygous mice show degeneration in both corticospinal 
motor neurons of the motor cortex and spinal motor neurons of the spinal cord and 
brainstem similar to human ALS patients. The degeneration of these cells begins before 
noticeable symptoms develop, and can be seen by postnatal day 30 (Özdinler et al., 2011). 
I was provided with cell populations from both wild type and heterozygous SOD1 mice 
that had been FAC-sorted for the presence of fluorescence driven by an MCP-1 promoter. 
These samples consisted of small populations from either the motor cortex or the lumbar 
region of the spinal cord of a single mouse, which I then prepared for microarray analyses 
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(Figure 1). As the immune response is apparently involved in ALS, differences in genes 
that modify immune responsiveness could provide valuable information about both the 
course of the disease and possible avenues of treatment.  
 
Methods 
Organism and Tissue Collection 
 The lumbar region of the spinal cord and the motor cortex region of the brain were 
dissected out of postnatal day 30 hSOD1G93A heterozygous mice and wild type mice. The 
collected tissues were then dissociated into single cells, which were then FAC-sorted for 
the presence of fluorescence linked to an MCP1 promoter and collected into RNAlater 
(Ambion). Three independent biological replicates were isolated and FAC-sorted for each 
population. 
 
RNA Isolation, Reverse Transcription and Amplification 
 RNA was isolated from each sample with the Reliaprep RNA Cell Miniprep Kit 
(Promega) according to the manufacturer’s instructions. A protocol, originally designed 
for the amplification of single cell cDNA (Trimarchi et al. 2007), was modified for 
generation of cDNA from FAC-sorted cells, in which 1 µl of sample was combined with 
.45 µl 10x PCR buffer (100mM Tris-HCl pH 8.3, 500 mM KCl, 2 mM MgCl2), .23 µl 
0.1M DTT, .05 µl SUPERase-In (Applied Biosystems), .05 µl RNase Inhibitor (Applied 
Biosystems), 0.13 µl 0.5 µm Oligo dT primer (TATAGAATTCGCGGCCGCTCGCG-
ATTTTTTTTTTTTTTTTTTTTTTTT), .09 µl 2.5 mM dNTP, and 3.5 µl dH2O. Samples 
were incubated at 70 ̊C for 90 seconds, then placed immediately on ice. 0.33 µl Superscript 
III reverse transcriptase, .05 µl RNase Inhibitor, and .07 µl T4 gene 32 protein were added 
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to each sample, which was then incubated at 50 ̊C for 50 minutes, inactivated at 70 ̊C for 
15 minutes, then placed on ice.  
Remaining single strand primer was then removed by adding 0.1 µl 10x 
Exonuclease buffer, 0.1 µl Exonuclease I, and 0.8 µl dH2O to each sample, incubating at 
37 ̊C for 30 minutes, inactivating at 80 ̊C for 25 minutes, and placing on ice. 
A poly-adenalated tail was then added by combining 0.6 µl 10x PCR buffer (same 
as prior), 0.18 µl 100 mM dATP, 0.3 µl Terminal Transferase (TdT) (Roche), 0.3 µl RNase 
H, and 4.62 µl dH2O to each sample, incubating at 37 ̊C for 20 minutes, inactivating at 
70 ̊C for 10 minutes, then placing on ice. 
Samples were amplified using 0.2 µl 100 µM Oligo dT primer (same sequence as 
prior), 10 µl 10x Ex Taq buffer, 10 µl 2.5 mM dNTP mix, 1 µl Taqara Ex Taq HS, and 
65.56 µl dH2O. All samples then underwent PCR programmed with the following steps: 
95 ̊C for 1 minute, 95 ̊C for 1 minute, 37 ̊C for 5 minutes, 72 ̊C for 16 minutes, 35 cycles 
of (93 ̊C for 40 seconds, 67 ̊C for 1 minute, 72 ̊C for 6 minutes + 6 seconds per cycle), 72 ̊C 
for 10 minutes, then held at 4 ̊C overnight.   
 
Microarray Analyses 
 In preparation for microarray, 15 µl of cDNA was combined with 1 µl DNase I, 8 
µl One-Phor-All buffer (0.5 M Potassium Acetate, 0.1 M Tris Acetate pH 7.6, 0.1 M 
Magnesium Acetate, in dH2O), and 61 µl dH2O. This mixture was incubated at 37 ̊C for 13 
minutes, followed by 100 ̊C for 15 minutes and then placed on ice. 20 µl 5x TdT buffer, 
2.5 µl Biotin N-6 ddATP, and 1 µl TdT (diluted 1:8 in TdT buffer) were added to each 
sample, then incubated at 37 ̊C for 90 minutes, followed by 65 ̊C for 5 minutes (Trimarchi 
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et al., 2007). Samples were hybridized to Affymetrix Mouse 430 2.0 expression arrays, 
according to manufacturer’s instructions.  
 Results were normalized in R, and then analyzed using the student’s t-test to 
determine statistical significance (p≤0.05) of differentially expressed genes in each motor 
cortex and spinal cord. Expression heatmaps were generated of the log transformed values 
of the 45 top differentially expressed genes in each motor cortex (Figure 3) and spinal cord 
(Figure 4) using Treeview (Eisen et al., 1998), where the absent calls were set to 0. The 
Cytoscape App BiNGO (Maere et al., 2005) was used to determine gene ontology clusters 
that were statistically overrepresented in the data (Figures 5 and 6). Significance was 
restricted to <0.005. 
 
Results and Discussion 
 This protocol (Trimarchi et al., 2007) was originally developed for use with single 
cells, so it was known that microarray experiments could be performed with very low 
starting concentrations. However, this project involved using populations of 1,000-5,000 
cells that had been sorted into RNAlater, so some troubleshooting was required. More 
specifically, both the RNA isolation and the cDNA amplification had to be optimized for 
these starting amounts. To ensure that the protocol was working and that the expected cell 
types were being isolated, 10 µl of the amplified cDNA was run on a gel to check the 
quality of DNA smears (Figure 2A).  Samples were then checked by PCR with primers for 
MCP1, CD11b, IBA-1, and GFAP (Figure 2B-C) to determine that samples did consist of 
the cell types desired. CD11b, also known as integrin alpha M, is expressed by multiple 
different cell types involved in the immune response (Pahl et al., 1992). IBA-1, also known 
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as allograft inflammatory factor 1, is thought to play a role in macrophage activation and 
function (Utans et al., 1996), and GFAP (glial fibrillary acidic protein) which marks mature 
astrocytes (Reeves et al., 1989). These markers were selected based on their coincidence 
with infiltrating immune cells observed in prior studies.  
Statistical analysis of the microarray results where p≤0.05 found 567 genes to be 
differentially expressed between SOD1 and wild-type (Wt) spinal cord tissues, and 255 
genes to be differentially expressed between SOD1 and Wt motor cortex tissues. The top 
45 of each of these tissues were visualized by heat map (Figures 3 and 4), and gene 
ontology was examined to determine more broad trends in the data (Figures 5 and 6).  
 As the microarray analysis of these samples provided numerous genes that were 
differentially expressed between wild type and SOD1 tissues, this provides a multitude of 
paths to further explore in disease mechanisms operating in ALS mouse models, which 
will hopefully lead to a greater understanding of ALS in human patients. Some genes 
related to the immune response are differentially expressed, such as the immunoglobulin 
heavy chain complex and chemokine (C-C motif) ligand 7. The exploration of these and 
other related genes could provide further insight into how the immune response is involved 
in disease progression. It could also be informative to look for markers of 
neurodegeneration mechanisms within these cell populations, including oxidative stress as 
that is one mechanism that has been seen in both ALS patients and animal models and is 
especially relevant to mutations in the SOD1 gene (Barber et al., 2006).  
 Another avenue of exploration could be looking into genes that encode proteins on 
the cell surface, including those that are involved in signaling pathways. With more study 
these could lead to potential drug targets for the treatment of ALS. As Riluzole remains the 
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only treatment since its approval in 1995 (Bellingham, 2011) even though it has only small 
effects on survival, anything new could allow for better treatment of this disease. Given 
that the immune response of ALS in both human patients and animal disease models 
appears to aggravate the condition, further investigation into inhibition of this immune 
response could be valuable in the search for better treatments. Due to the multifactorial 
nature of ALS, a combination of therapies will probably provide the best results, so any 
potential targets for small molecules identified could be highly beneficial.   
 As the cell population used probably consisted mostly of astrocytes and immune 
cells, this study has the potential to contribute to our understanding of how interactions 
between neurons and non-neuronal cells are involved in disease progression of ALS. There 
is still a considerable amount that remains unknown about the causes and progression of 
ALS. With the multitude of genes and pathways involved it is difficult to get results that 
are applicable to all ALS cases. However, looking into the immune responses could likely 
result in targets that could be more broadly applied. This study focused on a single mouse 
model, hSOD1G93A. The differentially expressed genes identified in this study could be 
helpful to further our understanding of ALS caused by mutant SOD1, and possibly the 
effects of the immune response on the general pathology of ALS. 
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Figures and Tables 
 
 
Figure 1: Visual representation of protocol from whole tissue to microarray results.   
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Figure 2: (A) cDNA smears were examined for each sample, Wt cx (wild-type motor 
cortex), Wt sc (wild-type spinal cord), SOD1 cx (transgenic SOD1 motor cortex), and 
SOD1 sc (transgenic SOD1 spinal cord). (B-C) Samples were checked for the presence of 
multiple markers to assess quality. Markers used include Cd11b (B), which is expressed 
by macrophages and microglia; GFAP (B), which marks mature astrocytes; Iba-1 (C), 
which marks macrophages; and MCP1 (C), the promoter for which was used to drive the 
RFP for FAC-sorting.  
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Figure 3: Heat map of the top 45 significant (p≤0.05) differentially expressed genes 
between SOD1 mutants and Wt mice in the motor cortex made using Treeview. Each 
column is a different sample and each row a different gene.  
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Figure 4: Heat map of the top 45 significant (p≤0.05) differentially expressed genes 
between SOD1 mutants and Wt mice in the spinal cord made using Treeview. Each column 
is a different sample and each row a different gene. 
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Figure 5: Gene ontology of motor cortex tissues, made using the Cytoscape app BiNGO. 
This map shows significantly overrepresented terms that are associated with significantly 
differentially expressed genes identified in the microarray experiments, with darker orange 
being more significant. The most significantly overrepresented terms for these tissues were 
those related to metabolic processes.  
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Figure 6: Gene ontology of spinal cord tissues, made using the Cytoscape app BiNGO. 
This map shows significantly overrepresented terms that are associated with significantly 
differentially expressed genes identified in the microarray experiments, with darker orange 
being more significant. The most significantly overrepresented terms for these tissues were 
those related to metabolic processes, signaling pathways, and transcriptional controls.  
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CHAPTER II 
CHARACTERIZATION OF SINGLE ENTERIC NEURONS IN 
ZEBRAFISH 
Abstract  
 The enteric nervous system (ENS) is responsible for proper function of the gut. It 
is regulated by a complex network of genes, mutations in some of which are known to 
cause medical problems including the human disorder, Hirschsprung's disease. In 
Hirschsprung's the enteric neurons fail to colonize the entire length of the gut during 
development, most likely due to problems during migration and proliferation. To further 
examine this colonization process, we are performing RNA sequencing on single enteric 
neurons from two different time points during development, 48 hours post fertilization and 
7 days post fertilization. These time points were chosen to compare the migrating precursor 
population of enteric neural crest cells (48 hpf) to the differentiated enteric neurons (7 dpf). 
This study should expand our knowledge of signaling pathways and other genes involved 
in migration, proliferation, and differentiation of the ENS, as well as identify specific 
markers of precursors and enteric neurons.  
 
Introduction 
The Enteric Nervous System 
 The enteric nervous system (ENS) is vastly important for digestive function. The 
ENS consists of enteric neurons and glia along the gastrointestinal (GI) tract that work in 
concert with the smooth muscle and interstitial cells of Cajal (ICC)  to move food through 
the GI tract (Burns et al., 2009; Burns & Pachnis, 2009; Olsson & Holmgren, 2001). The 
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enteric neurons are derived from the neural crest and migrate to the gut during development 
(Barlow et al., 2008; Burns & Pachnis, 2009). In zebrafish the ENS is fully innervated by 
66 hours post fertilization (hpf) (Burns et al., 2009), and is fully functional by 5 days post 
fertilization (dpf) (Wallace & Pack, 2003). ENCC populate the gut from 36 hpf to 74 hpf, 
with differentiation thought to begin around 72 hpf (Wallace et al., 2004). The number and 
distribution of these cells expressing neural-specific markers increases between 96 and 120 
hpf (Wallace et al., 2004), suggesting widespread differentiation.  
 
ENS development 
The ENS is neural crest derived, along with other neuronal and glial cells of the 
peripheral nervous system, craniofacial structures, and pigment cells (Burns & Pachnis, 
2009). To form the ENS, neural crest cells (NCC) migrate from somites 1-7 of the vagal 
region of the hindbrain and into the endoderm, then along the gut tube in a rostrocaudal 
direction (Le Douarin & Teillet, 1973; Barlow et al., 2008). This neural crest origin was 
first observed in 1954, in a study where the entire vagal region of the neural tube was 
ablated in chick embryos, which led to a loss of the enteric neurons (Yntema & Hammond, 
1954). Another study in chick embryos further explored this region of origin by taking 
ablation studies of somites 1-7 one step further. After ablation, quail NCC cells from 
somites 1 and 3 were transplanted into different regions in separate experiments. The 
transplantation of quail NCC cells from somite 3 into the corresponding position in a chick 
embryo was sufficient to recapitulate the colonization and formation of the ENS (Barlow 
et al., 2008). 
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 The exact mechanism and signals involved in this migration are still being studied, 
but there are multiple suggestions of certain factors that are important for this process. 
Some studies suggest that the ENCC migration is mainly driven by the proliferation of 
ENCCs at the wavefront (Burns et al., 2009), while others have shown that the size and 
somite of origin of the ENCC progenitor pool is significant to affect ENS development 
(Barlow et al., 2008). A study in mice showed that the neural crest cells form chains of 
cells that have complicated patterns of migration, while single ENCC can make sudden 
changes in speed and direction during migration (Young et al., 2014).  All of these 
processes are controlled by a wide range of genes encoding for transcription factors and 
proteins involved in signaling pathways. 
 In mouse and chick studies, it has been shown that neural crest cells (NCC) at the 
sacral end of the neural tube also make a contribution to the ENS. These cells do not 
directly populate the gut, but rather form ganglia adjacent to the gut wall.  The sacral neural 
crest cells populate the caudal intestine and colon by following nerve fibers into the gut 
(Burns et al., 2009). Transplantation studies carried out between the sacral and the vagal 
NCC populations, in which cells from one region were transplanted into the other, 
demonstrated that these cells retained aspects of their original developmental roles (Burns 
et al., 2009). In this study the vagal neural crest cells in the sacral position colonized the 
gut in a rostrocaudal direction, and the sacral neural crest cells in the vagal position were 
much less invasive and were incapable of colonizing the entire gut (Burns et al., 2009). 
This study suggests that there are intrinsic differences between these two populations of 
ENCC. 
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Molecular Basis of ENS development 
 There are numerous genes that have been shown to play a role in the development 
of the enteric nervous system. Several signaling pathways have been shown to be important 
in the development and function of the ENS, including the RET-GDNF pathway, and 
ENDRB (endothelin receptor type B) (Burns et al., 2009; Sasselli et al., 2012). RET (a 
receptor tyrosine kinase) has been seen expressed in migratory ENCC and after 
differentiation is exclusively expressed by the neurons. GDNF (glial line-derived 
neutrophic factor) is its receptor. Mutations in either RET or GDNF result in intestinal 
agangliosis (Barlow et al., 2008; Burns et al., 2009; Sasselli et al., 2012; Fernández et al., 
2013). ENDRB and its ligand are involved in ENCC differentiation (Barlow et al., 2008; 
Burns et al., 2009), promoting the colonization of the gut by undifferentiated progenitors. 
This can affect other pathways, as endothelin 3 (ET-3) can increase RET-GDNF induced 
proliferation, and mutations in ET-3 can increase the severity of Sox10 (SRY box 10) 
mutant mice (Sasselli et al., 2012; Young et al., 2014).  
Transcription factors are also considerably involved with ENS development 
(Sasselli et al., 2012). Sox10 is a transcription factor that is expressed in the migratory 
ENCC (Barlow et al., 2008; Burns et al., 2009). It is present in the progenitor population, 
but after these cells differentiate it is expressed only in the glial cells. It is believed to play 
a significant role in the survival of the undifferentiated progenitor cells, as the absence of 
Sox10 results in a dramatic increase of ENCC death (Sasselli et al., 2012). Sox10 also 
appears to affect EDNRB and regulate RET and another transcription factor, Phox2b 
(Sasselli et al., 2012).  Phox2b (paired-like homeobox 2b) is involved with ENCC 
development (Burns et al., 2009), is expressed in ENCC, and has been shown to persist in 
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differentiated enteric neurons and glia. Mutations in Phox2b lead to a loss of automatic 
neurons and ganglia, and a failure of NCC to express RET (Sasselli et al., 2012). There is 
a wide range of genes that encode for proteins in signaling pathways and transcription 
factors that are important for ENS development (Barlow et al., 2008; Burns et al., 2009; 
Sasselli et al., 2012). Those described here are only a few representative examples. 
 
Gut Function/Motility  
 The movement of the gut occurs by two different motor patterns, the segmentation 
and the peristaltic waves. The segmentation pattern consists of alternating stationary waves 
that mix the contents of the GI tract with digestive enzymes and allow for the constant 
turnover of nutrients into the epithelium of the gut. The peristaltic waves consist of 
contractions that move the contents of the GI tract in a rostrocaudal direction (Burns et al., 
2009; Olsson & Holmgren, 2001). These motor activities are influenced by the ICCs, which 
are thought to act as the pacemaker cells within the smooth muscle of the epithelium 
(Olsson & Holmgren, 2001).   
 
Hirschsprung’s Disease 
 Failure of any biological process during development can lead to subsequent 
problems with the organism, and mutations that affect the development of the gut are 
certainly no exception. The most common congenital gut motility disorder in humans is 
known as Hirschsprung’s disease (HSCR) (Kenny et al., 2010). This disorder, named after 
the surgeon who discovered it, is characterized by an absence of neurons in the caudal end 
of the GI tract and appears to be the result of neurons failing to fully migrate and colonize 
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the GI tract (Burns et al., 2009; Kenny et al., 2010; Sasselli et al., 2012; Fernández et al., 
2013). The current treatment of HSCR involves surgically removing the affected part of 
the GI tract, which often results in numerous subsequent problems later in life (Kenny et 
al., 2010). HSCR occurs in about 1 in 5000 live births and has been linked to multiple 
genes including RET-GDNF, EDNRB, and Sox10 (Barlow et al., 2008), which is not 
surprising as these are all important for ENS development (Barlow et al., 2008; Burns et 
al., 2009; Sasselli et al., 2012). HSCR is also known to be associated with multiple 
disorders, including both Down’s syndrome and Waardenburg Syndrome (Kenny et al., 
2010).  
Multiple genetic screens have been carried out to identify other genes that may play 
critical roles in ENS development in a variety of model organisms (Southard-Smith et al., 
1998; Pietsch et al., 2006; Kuhlman and Eisen 2007; Zhang & Niswanter, 2013), and yet 
characterization of these genes remains incomplete (Kelsh & Eisen, 2000). Those screens 
that have resulted in the discovery of mutants with defects in the ENS often serve as disease 
models for HSCR (Southard-Smith et al., 1998; Pietsch et al., 2006; Kuhlman and Eisen 
2007; Zhang & Niswanter, 2013). A zebrafish mutant lacking Sox10 lacks nearly all enteric 
neurons and glia (Kelsh & Eisen, 2000; Kuhlman & Eisen, 2007), as does its mammalian 
counterpart (Southard-Smith et al., 1998), which shows that zebrafish can have similar 
phenotypes to human patients, and are a viable model for human diseases such as HSCR. 
As HSCR appears to be the result of ENCC failing to migrate the entire length of the gut, 
exploring the expression profiles of migrating cells could provide valuable insight into the 
causes and possible therapies for this disease. 
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Single Cell Transcriptomics 
 Not only is the gut made up of multiple cell types, but in the case of the ENCC it 
has been shown that a population of ENCC begins to differentiate prior to full colonization 
of the gut. This population sends out projections that follow the caudal advance of ENCC 
(Young, et al., 2014). This population suggests that there are distinct subtypes of ENCC.  
Examining these cells on the single cell level provides the potential of identifying genes 
involved in determining enteric neuron subtypes, precursors, and regulatory elements. 
Performing RNA sequencing on single cells provides a challenge, but one worth pursuing 
(Pan, 2014), as studying this heterogeneous population one cell at a time could show new 
variations in ENCC. RNA-seq allows for the deep sequencing of the transcriptome, so that 
the complete set of transcripts being expressed by a tissue, or in this case a cell, and their 
relative quantity can be observed (Wang et al., 2009). By exploring these expression 
profiles genes that characterize subsets of enteric neurons, or specifically mark enteric 
neuron precursors, could be determined for future studies. Of greater interest to the study 
of HSCR, genes could be identified in these expression profiles that regulate ENCC 
proliferation and migration.  
 
Project Goals 
 The goal of this project was to isolate single enteric neurons based on fluorescence 
driven by a Phox2b promoter and perform RNA-seq to discover genes involved in ENS 
development (Figure 1). Phox2b is a transcription factor expressed in migrating NCC that 
continues being expressed in different enteric neuron and at least a subset of enteric 
neurons in the adult, so isolation of cells based on expression of the Phox2b promoter 
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should allow for a variety of ENCC subsets to be studied at both 48 hpf and 7 dpf. We hope 
to further our understanding of gene networks and signals that direct and influence enteric 
neuron proliferation, migration, and differentiation. Investigation of these two time points 
will allow for the comparison of gene expression between enteric neurons and their 
precursors, and to elucidate the changes in gene expression as ENCC finish migrating and 
differentiate.   
 
Materials and Methods 
 Organism and Cell Dissociation  
 Transgenic fish with a GFP reporter driven by a Phox2b promoter 
(Tg(Phox2b:GFP)) (Nechiporuk et al., 2007) were used in these experiments (Figure 2). 
The fish displaying GFP positive cells in the gut were selected at 48 hpf and 7 dpf. At these 
two time stages, the guts of multiple fish were dissected out and dissociated using 360 
microliters (µl) of HBSS/HEPES mixture, 20 µl of CysEDTA mixture and 20 µl of 
activated papain. The 7 dpf tissues were incubated at 37 ̊C for a total of 30 minutes, while 
the 48 hpf tissues were incubated at the same temperature for a total of 20 minutes. 
Dissociated tissues were then treated with 5 µl of DNase I to prevent clumps caused by 
DNA released from dying cells and incubated at room temperature for 5 minutes. Samples 
were centrifuged for 3 minutes at 3000 rpm, following which the supernatant was removed, 
the pellet was resuspended in 1 milliliter of HBSS, and samples were re-spun at the same 
conditions to ensure all DNase and papain is washed away. The supernatant was then 
discarded and the pellet was resuspended in 200 µl of PBS containing 1% BSA by volume, 
then plated in 5 milliliters (ml) of PBS+1%BSA in glass petri dishes for single cell 
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isolation. These conditions were determined after a few initial experiments to maximize 
the length of time before cells started sticking to the petri dish.  
 
 Harvesting Single Cells 
 Cells were allowed to settle for 5 minutes before isolating single cells. Single cells 
were isolated using pulled glass needles and a mouth aspirator according to Goetz and 
Trimarchi (2012). Cells were selected based on the presence of GFP. Isolated cells were 
placed into 0.5 ml tubes containing 5 µl of total cell lysis buffer (Qiagen) with 1% 2-
Mercaptoethanol by volume. Samples were then stored at -80 ̊C for up to two weeks.  
 
Cell Lysis, Reverse Transcription and Amplification of cDNA 
 Samples were thawed at room temperature and 5 µl of nuclease-free dH2O was 
added to bring each sample up to a volume of 10 µl. 22 µl of well-mixed Agencourt RNA 
Clean XP beads were added to each sample, and left at room temperature for 5 minutes. 
Samples were then placed on MagnaBlot II Magnetic Separator and let stand until 
supernatant was clear of beads. Following this, all supernatant was removed and the pellet 
was washed 3 times with 70% ethanol. After all ethanol was removed, pellets were air-
dried, then samples were removed from the magnetic plate and 1 µl of dH2O, 1 µl 3’ 
SMART CDS Primer II A (12 µM), and 2.5 µl of reaction mix (1 µl RNase Inhibitor:19 µl 
Dilution Buffer) were added directly onto the pellet to rehydrate.  
 Reverse transcription and cDNA amplification were performed according to 
manufacturer’s instructions using the Clontech SMARTer Ultra Low RNA Kit. 
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Amplification was performed for 31 PCR cycles and samples were stored at -20 ̊C after 
bead purification with SPRI Ampure Beads.  
 
Quality Control  
 Samples were run on the Agilent 2100 Bioanalyzer using a high sensitivity DNA 
chip to assess the quality of the samples before proceeding (Figure 3B). cDNA was also 
checked by RT-PCR for presence of multiple markers, including Phox2b, which should be 
present in all samples as cells were isolated according to presence of GFP linked to a 
Phox2b promoter. The other markers used were crestin, which should label all neural-crest 
derived cells prior to 72 hpf (Luo et al., 2001), elavl3, which plays a role in neurogenesis 
(Van Tine et al., 2000), and neural crest progenitor markers foxd3 (Sasai et al., 2001; 
Pietsch et al., 2006) and Sox10 (Sasselli et al., 2012; Pietsch et al., 2006). The results of 
these marker amplifications were run out on a 1% agarose gel (Figure 3A). Sample 
concentrations were obtained using the Qubit DNA High Sensitivity Assay Kit (Life 
Technologies).  
 
Fragmenting and Barcoding 
 48 hpf cells were fragmented and indexed using the Nextera DNA Sample Prep Kit. 
50 nanograms of each sample in 20 µl were added to 25 µl Tagment DNA buffer and 5 µl 
Tagment DNA enzyme, then incubated at 55 ̊C for 5 minutes to fragment the cDNA. 
Samples were then purified with the NucleoSpin Gel and PCR Clean-up Kit, according to 
manufacturer’s instructions. The only modification was at the elution step, when samples 
were eluted into 25 µl Resuspension buffer from the Nextera kit. 20 µl of purified sample 
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was combined with 15 µl Nextera PCR Master Mix, 5 µl PCR Primer Mix, 5 µl selected 
index 2 primer, and 5 µl index 1 primer. This mixture was placed into a thermal cycler that 
was programmed with the following steps: 72 ̊C for 3 minute, 98 ̊C for 30 seconds, 8 cycles 
of (98 ̊C for 10 seconds, 63 ̊C for 30 seconds, 72 ̊C for 3 minutes), held at 10 ̊C. 
To purify PCR product, 30 µl DNA beads were mixed into each sample, incubated 
room temperature for 5 min, then placed on magnetic separation device for 2 minutes. The 
clear supernatant was discarded, following which two 80% Ethanol washes were done with 
200 µl each. All Ethanol was removed, and the samples were allowed to air-dry for about 
4 minutes. As soon as the pellets were dry, samples were removed from magnetic stand, 
and beads were resuspended in 27.5 µl resuspension buffer. Samples were incubated at 
room temperature for 2 minutes and then placed back on magnetic stand for 2 minutes. 25 
µl of the supernatant was removed without disturbing the beads, placed into new tubes, and 
stored at -20C. 
These samples were analyzed via Bioanalyzer (Figure 4). Adapters selected for 
each cell can be found in Table 1. Concentrations of each sample were obtained using the 
Qubit and then diluted to a concentration of 2 nM in 10 µl using Tris-Cl 10 mM, pH 8.5 
with 0.1% Tween 20. 5 µl of each sample were then combined in a new tube, vortexed 
briefly and stored at -20 ̊C until ready for sequencing.  
7 dpf cells were sheared using the Covaris S220 Focused-ultrasonicator, after which 
the fragments were assessed on the Agilent 2100 Bioanalyzer using a high sensitivity DNA 
chip (Figure 4). Adapters and individual barcodes were added using Illumina’s TruSeq 
DNA LT Sample Prep Kit. Adapter selected for each cell can be found in Table 2. Samples 
were then normalized to 10 nM using Tris-Cl 10 mM, pH 8.5 with 0.1% Tween 20. 10 µl 
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of each sample were then combined in a new tube, vortexed briefly and stored at -20 ̊C 
until ready for sequencing. 
 
Results and Discussion 
 Twelve cells were isolated from each time point. In both the 48 hpf cells (table 1) 
and the 7 dpf cells (table 2), different sets of markers were seen in the individual isolated 
cells. This suggests that a range of enteric neuron subtypes were isolated for RNA-seq in 
this set of experiments.  As crestin, a pan neural crest marker, begins to be downregulated 
in differentiating crest cells (Luo et al., 2001), all isolated cells expressing crestin are likely 
to be enteric neuron precursors. Those coexpressing crestin and Elavl3 could be cells that 
are undergoing the transition from precursors to differentiated neurons.  As Elavl3 marks 
neurons (Van Tine et al., 2000), it makes sense that more cells from the 7dpf time point 
appear to be expressing this gene, and more 48 hpf cells have Foxd3 or Sox10, both of 
which mark enteric neuron precursors (Sasai et al., 2001; Pietsch et al., 2006; Sasselli et 
al., 2012). All of this preliminary data suggests that mostly enteric neuron precursors were 
isolated from the 48 hpf time point, while those isolated from the 7dpf time point are mostly 
enteric neurons.  
At this point in the study all cells from both 48 hpf and 7 dpf have been sent for 
sequencing, but results are not yet available. Once sequenced the reads will be mapped 
back to the zebrafish genome, and results will need to be validated using either qPCR or in 
situ hybridization to support expression profiles determined by RNA-seq. A parallel study 
is being performed by the Kuhlman lab that entails RNA-sequencing on populations of 
FAC-sorted cells from the same transgenic line used in this study. Using a similar method, 
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they are dissecting out the guts of 48 hpf and 7 dpf zebrafish larvae and FAC-sorting based 
on the presence of GFP linked to a Phox2b promoter.  
Examination of differences in gene expression profiles between 48 hpf and 7 dpf 
should be enlightening. This study should provide markers that can distinguish between 
enteric neurons and their precursors, in addition to revealing signals and factors involved 
in the transition from migration and proliferation to differentiation. The exploration of 
genes that play a role in migration and proliferation of ENCC could suggest new targets or 
paths of research into the etiology and treatment of Hirschsprung’s disease and other 
similar conditions. Investigating genes already known to be involved in ENS development 
is also important, as the comparison of 48 hpf expression profiles and 7 dpf expression 
profiles could further illustrate how these pathways function in ENS development. This 
would also be helpful to fully characterize existing ENS mutants. Characterization of single 
enteric neurons at additional time points, both in development and adulthood, would further 
add to our knowledge of ENS development and function.    
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Figures and Tables 
 
 
Figure 1: Visual representation of protocol.  
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Figure 2: Tg(Phox2b:GFP)  fish at (A) 48 hpf and (B) 7 dpf. At 48 hpf the enteric neural 
crest cells are migrating and populating the gut tube, as can be seen in the lower panel. At 
7 dpf the enteric neurons are differentiated and the ENS is fully functional. 
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Figure 3: Quality control of samples after reverse transcription and amplification involving 
(A) PCR of genes to check for enteric neuron progenitor markers and (B) running the 
sample on an Agilent 2100 Bioanalyzer. Markers used include crestin, which marks neural-
crest derived cells prior to differentiation; Elavl3, which marks differentiated neurons; 
Foxd3 and Sox10, both of which mark enteric neuron precursors; and Phox2b, which marks 
enteric neuron precursors and remains on in differentiated enteric neurons.  
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Figure 4: (A) 48 hpf cell fragmented using Nextera DNA Prep Kit. (B) 7 dpf cell 
fragmented using the Covaris S220 Focused-ultrasonicator. These bioanalyzer results, 
when compared to bioanalyzer results to assess quality of cDNA, show that the cDNA has 
been fragmented for sequencing. 
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Table 1: Markers expressed by each 48 hpf cell and the adapters used during preparation 
for sequencing. Different cells express different subsets of markers, suggesting that 
different subtypes of enteric neural crest cells may have been isolated. Many of these cells 
express enteric precursor markers, which is expected for this time point. A few cells (E, G, 
K) also express Elavl3, suggesting the existence of an early differentiating population. 
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Table 2: Markers expressed by each 7 dpf cell and the adapters used during preparation for 
sequencing. Most of the cells express Elavl3, which is consistent with this time point, as 
the cells are all expected to be differentiated neurons. Interestingly, some of these 7 dpf 
cells (e, h-j) also express crestin, which should mark the undifferentiated enteric neural 
crest cells. This suggests that these cells are transitioning from the migratory and 
proliferation to differentiation.  
 
  
Individual cell 
Designation Time point Phox2b Elavl3 Crestin Sox10 Foxd3
Method of 
Barcoding
Adapter 
Used
cell e 7 dpf X X X
Illumina 
Truseq 13
cell g 7 dpf X X
Illumina 
Truseq 14
cell h 7 dpf X X X
Illumina 
Truseq 15
cell i 7 dpf X X X
Illumina 
Truseq 16
cell j 7 dpf X X X
Illumina 
Truseq 18
cell l 7 dpf X X
Illumina 
Truseq 4
cell m 7 dpf X X
Illumina 
Truseq 19
cell p 7 dpf X X
Illumina 
Truseq 12
cell q 7 dpf X X X
Illumina 
Truseq 2
cell r 7 dpf X X
Illumina 
Truseq 5
cell s 7 dpf X X
Illumina 
Truseq 6
cell t 7 dpf X X
Illumina 
Truseq 7
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APPENDIX 
DEVELOPING A TRANSIT ASSAY OF GUT MOTILITY IN 
ZEBRAFISH 
Abstract 
 To examine the role of enteric neurons in gut motility, and measure motility in the 
larval zebrafish we are developing a transit assay. Using fluorescent beads and a 
modification of an egg yolk feeding assay developed by Carten et al (2008), we are 
developing an assay to measure the rate of clearance of fluorescently labeled food. By 
measuring the transit time and rate of clearance, we can examine relative changes in 
intestinal motility. To determine whether this assay is sensitive enough to detect changes 
in motility patterns, we are testing it using the chemical dextran sodium sulfate (DSS), a 
chemical that is known to cause inflammation of the intestine in mouse and zebrafish. We 
found that DSS appears to increase transit time and suggests with further testing this transit 
assay could be an efficient method in future to measure potential differences in transit rates 
among enteric nervous system mutants in zebrafish.  
 
Introduction 
The motility of the gut is controlled by the enteric nervous system (ENS), which is 
made up of neurons and glial cells that line the gastrointestinal (GI) tract. Along with the 
smooth muscle of the gut and the interstitial cells of Cajal (ICC), the ENS controls two 
different types of gut motility (Burns and Pachnis, 2009). Peristalsis is the movement of 
food along the gut, while segmentation is responsible for the mixing of food (Kenny et al., 
2010). There are multiple human disorders that affect gut motility, including 
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Hirschsprung’s disease and Waardenberg’s Syndrome, both of which are a result of a lack 
of neurons at the caudal end of the gut (Kenny et al., 2010). Patients with Inflammatory 
Bowel Disease (IBD), caused by an inflammation of the intestine also have affected gut 
motility (Fleming et al., 2010).   
 The genetic bases of these disorders has been widely studied but it is not clear how 
the different mutations can affect the movement of the gut differently (Burns & Pachnis, 
2009). One way to visualize these differences in motility is with a transit assay (Field et 
al., 2009). Zebrafish are ideally suited to study this, as their GI tract is fully functional at 5 
days post fertilization (dpf) (Wallace & Pack, 2003), and their optical transparency at larval 
stages allows easy visualization of the intestinal tract (Fleming et al., 2010). To examine 
the role of enteric neurons in gut motility, and measure motility in the larval zebrafish we 
are developing a transit assay using fluorescent beads and a modification of an egg yolk 
fatty acid feeding assay (Carten et al., 2011). To determine whether this assay is sensitive 
enough to detect changes in motility patterns, we are testing it using the chemical dextran 
sodium sulfate (DSS), known to cause inflammation and potentially serve as a model for 
IBD (Oehlers et al., 2013). 
 
Methods 
 Approximately 18 hours before the start of the experiment, 7-10 dpf zebrafish 
larvae were placed into petri dishes of fresh water with 5% sonicated egg yolk and 
FluoSpheres (Invitrogen), fluorescently labeled microspheres (2um)(cat # F-8826) . The 
egg yolk-bead mixture was sonicated at 4 watts for 2-3 minutes. The larvae were left in 
this solution overnight, and sorted the next morning based on the amount of fluorescently 
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labeled food ingested. Larvae with intestinal tracts filled with the fluorescent bead-yolk 
mixture were selected for further experiments. Larvae were removed from egg mixture, 
washed and placed in fresh water, then photographed under a dissecting microscope every 
few hours until the yolk-bead mixture had completely transited through the intestinal tract 
and their guts emptied.  
 Once the basic transit assay was consistent, transit time was manipulated with the 
addition of DSS. Initial experiments identified an optimal concentration of 0.25% DSS in 
water by volume that would not cause lethality of the larvae. The larval fish were placed 
in 0.25% DSS after the initial sorting, and they remained in this solution as they were 
photographed every few hours until their intestines appeared empty of beads and yolk. 
Results from treated and untreated were compared. 
 
Results and Discussion  
 The fish consistently ate the fluorescent FluoSphere beads when mixed with egg 
yolk. Transit time among larvae was highly variable, consistent with prior observations 
(Field et al., 2009), however the fish placed in 0.25% DSS consistently emptied their guts 
faster than those kept in water. This was usually the difference of about 2 hours between 
DSS treated larvae and control larvae (Figure 1).  
DSS has been shown to lead to inflammation in the gut, making it a good model of 
IBD (Oehlers et al., 2013). Our results demonstrate that this use of DSS can induce 
observable differences in transit time, but further studies must be done to confirm and 
extend these observations, as well as to determine by histological methods whether our use 
of this chemical is inducing widespread intestinal inflammation. A method of 
46 
 
quantification also remains to be determined for this assay, possibly by counting the beads 
or measuring the fluorescence in the gut or the water. Once it has been quantified, this 
transit assay can be applied to the study of ENS mutants and disease models in zebrafish 
to characterize how different mutations affect the motility of the gut.   
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Figures 
 
 
Figure 1: A pair of 9 dpf zebrafish larvae, photographed at 68x magnification. These larvae 
were fed a mixture of egg yolk and FluoSpheres overnight. The 0.25% DSS experimental 
larva (A) was empty just after 5 hours, while the H2O control larva (B) was empty at 7 
hours.  
 
